+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Interim analysis of a multicenter phase-II trial using high-dose sequential chemotherapy and autologous stem cell support for relapsed or refractory Hodgkins and non-Hodgkins lymphoma



Interim analysis of a multicenter phase-II trial using high-dose sequential chemotherapy and autologous stem cell support for relapsed or refractory Hodgkins and non-Hodgkins lymphoma



Annals of Hematology 77(SUPPL 2): S214




(PDF emailed within 1 workday: $29.90)

Accession: 031992236

Download citation: RISBibTeXText


Related references

Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkins and aggressive non-Hodgkins lymphoma Results of a multicenter phase-II study. Blood 98(11 Part 1): 681a, November 16, 2001

High dose chemotherapy with peripheral blood stem cell transplantation for patients with relapsed/refractory Hodgkins disease and non-Hodgkins lymphoma A randomized phase III comparison of two regimens. Blood 96(11 Part 1): 482a, November 16, 2000

A phase II trial of filgrastim support high dose sequential chemotherapy and peripheral blood stem cell transplantation as initial therapy for high risk Non-Hodgkins Lymphoma A multicenter pilot study. Blood 88(10 SUPPL 1 PART 1-2): 118A, 1996

Cologne high-dose sequential chemotherapy in relapsed and refractory aggressive Non-Hodgkins lymphoma Results of multicenter phase II Study. Blood 102(11): 405a, November 16, 2003

High dose chemotherapy with BCNU, cytarabine, cyclophosphamide, and etoposide and autologous stem cell rescue for relapsed, chemotherapy sensitive non Hodgkins lymphoma and Hodgkins disease. Blood 94(10 SUPPL 1 PART 2): 406b, Nov 15, 1999

Phase I clinical trial of Zevalin in patients with B-cell non-Hodgkins lymphoma with relapsed disease following high-dose chemotherapy and autologous stem cell transplantation. Blood 102(11): 30a, November 16, 2003

High-Dose Sequential Chemotherapy in Relapsed or Refractory Hodgkins and Non-Hodgkins Lymphoma. Blood 100(11): Abstract No 5462, November 16, 2002

R-DHAP - Preliminary Safety and Feasibility Data of Sequential High-Dose Chemotherapy with Autologous Stem Cell Support in Combination with the Anti-CD20 Antibody Rituximab in Relapsed Aggressive Non-Hodgkins Lymphoma. Blood 100(11): Abstract No 4737, November 16, 2002

High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II study. Annals of Oncology 16(8): 1359-1365, 2005

A phase II trial of filgrastim supported high dose sequential chemotherapy and peripheral blood stem cell transplantation as initial therapy for high risk non-Hodgkins lymphoma A multicenter pilot study. Blood 86(10 SUPPL 1): 964A, 1995

Autologous blood stem cell transplantation after sequential high-dose chemotherapy with modified BEAM in relapsed non-Hodgkins lymphoma Feasibility and toxicity in a single center study. Annals of Hematology 77(SUPPL 2): S150, 1998

Patterns of Failure and Survival Outcomes after Total Lymphoid Irradiation and High-Dose Chemotherapy with Autologous Stem-Cell Transplantation for Relapsed or Refractory classical Hodgkins Lymphoma. International Journal of Radiation Oncology*Biology*Physics 102(3): S124-S125, 2018

High-dose busulfan , VP-16, and ARA-C with peripheral blood progenitor cell support for patients with refractory and relapsed Hodgkins and non-Hodgkins lymphoma. Blood 88(10 SUPPL 1 PART 1-2): 124A, 1996

Phase I Study of Involved Field Radiation Therapy Preceding High Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with High Risk Hodgkins Disease and Non-Hodgkins Lymphoma. Blood 100(11): Abstract No 3405, November 16, 2002

High dose chemotherapy with Ifosfamide, etoposide and carboplatin supported with autologous refrigerated peripheral blood stem cells in the treatment of relapsed Non Hodgkins Lymphoma and Hodgkins Disease. British Journal of Haematology 93(SUPPL 2): 371, 1996